Sell (SEVELAMER CARBONATE) FOSBIND 800mg/30 tablets best price

Indications/Uses Sevelamer Carbonate is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. The safety and efficacy of Sevelamer Carbonate in CKD patients who are not on dialysis have not been studied. Dosage/Direction for Use Because of the rapid disintegration of the carbonate salt tablet and its rapid reaction with the hydrochloric acid in the stomach, the dosing of Sevelamer Carbonate is anticipated to be similar to that of the hydrochloride salt. Patients Not Taking a Phosphate Binder. The recommended starting dose of Sevelamer Carbonate is 800 to 1600 mg, which can be administered as one or two Sevelamer Carbonate 800 mg Tablets, with meals based on serum phosphorus level. Table 3 provides recommended starting doses of Sevelamer Carbonate for patients not taking a phosphate binder.